Category: Press Release - Page 49 - Psychedelic Alpha

Read more about the article Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of Phase 1 First-In-Human Clinical Trial Plan for Its Lead Clinical Candidate, MSP-1014

Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of Phase 1 First-In-Human Clinical Trial Plan for Its Lead Clinical Candidate, MSP-1014

Post published:September 14, 2022
Post category:Press Release

Read more about the article Sunstone Therapies Collaborates with MAPS to Conduct Clinical Trial of MDMA-Assisted Therapy for PTSD

Sunstone Therapies Collaborates with MAPS to Conduct Clinical Trial of MDMA-Assisted Therapy for PTSD

Post published:September 14, 2022
Post category:Press Release

Read more about the article Small Pharma Enters Into Automatic Share Purchase Plan

Small Pharma Enters Into Automatic Share Purchase Plan

Post published:September 13, 2022
Post category:Press Release

Read more about the article Numinus provides update on acquisition integration and announces new client financing options

Numinus provides update on acquisition integration and announces new client financing options

Post published:September 13, 2022
Post category:Press Release

Read more about the article Nature Biotechnology Selects Delix Therapeutics as a Leading Biotech Start-Up

Nature Biotechnology Selects Delix Therapeutics as a Leading Biotech Start-Up

Post published:September 13, 2022
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Receives Approval for Groundbreaking Phase 1 DMT Human Stroke Study

Algernon Pharmaceuticals Receives Approval for Groundbreaking Phase 1 DMT Human Stroke Study

Post published:September 13, 2022
Post category:Press Release

Read more about the article Braxia Scientific Launches KetaMD in Florida; First Patients Complete Initial Virtual Ketamine Treatments At-Home

Braxia Scientific Launches KetaMD in Florida; First Patients Complete Initial Virtual Ketamine Treatments At-Home

Post published:September 12, 2022
Post category:Press Release

Read more about the article Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022

Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022

Post published:September 11, 2022
Post category:Press Release

Read more about the article Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences

Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences

Post published:September 9, 2022
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Secures Lead Sponsorship of 2022 Wonderland Psychedelic Conference in Miami

Algernon Pharmaceuticals Secures Lead Sponsorship of 2022 Wonderland Psychedelic Conference in Miami

Post published:September 9, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.